Study for the efficacy and safety of oral semaglutide in subjects with type 2 diabetes - Trial UMIN000050583
Access comprehensive clinical trial information for UMIN000050583 through Pure Global AI's free database. This Phase 4 trial is sponsored by Hokkaido University Hospital and is currently Recruiting. The study focuses on Type 2 diabetes.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to University Hospital Medical Information Network data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Free Database
Powered by Pure Global AI
840K+ Trials
UMIN000050583
Phase 4
Recruiting
Trial Details
University Hospital Medical Information Network • UMIN000050583
Study for the efficacy and safety of oral semaglutide in subjects with type 2 diabetes
Study for the efficacy and safety of oral semaglutide in subjects with type 2 diabetes -retrospective observation trial
Study Focus
Observational
Sponsor & Location
Hokkaido University Hospital
Japan
Timeline & Enrollment
Phase 4
Oct 19, 2022
N/A
ICD-10 Classifications
Type 2 diabetes mellitus
Type 2 diabetes mellitus without complications
Type 2 diabetes mellitus with unspecified complications
Type 2 diabetes mellitus with other specified complications
Type 2 diabetes mellitus with multiple complications
Data Source
University Hospital Medical Information Network
UMIN000050583
Non-Device Trial